Skip to main content
SpringerLink
Log in

Genetic polymorphisms of adrenergic receptors

  • Review Article
  • Published:
Clinical Autonomic Research Aims and scope Submit manuscript

Abstract

Recent advances in molecular biology have enhanced the understanding of adrenergic receptors. They have allowed the characterization of the several subtypes of adrenergic receptors expressed and have expanded the research about the potential physiologic functions they mediate. Furthermore, variant forms, orpolymorphisms, of the genes that code for these receptors are being identified. These genetic variants may or may not result in functional differences in the receptors they encode. There is obvious interest in determining the physiologic and clinical relevance of these polymorphisms. The purpose of this review is to describe these polymorphisms and the often contradictory literature pertaining to their clinical significance. Progress in this area is being made at a rapid pace. As the allele-disease relations become less equivocal, it might be possible to predict individual differences in susceptibility to a disease, disease prognosis, and response to treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Ahlquist RP. A study of the adrenotropic receptors.Am J Physiol 1948; 153:586–600.

    CAS  Google Scholar 

  2. Johnson M. The beta-adrenoceptor.Am J Respir Crit Care Med 1998; 158:S146-S153.

    CAS  PubMed  Google Scholar 

  3. Bunemann M, Hosey M. G-protein coupled receptor kinases as modulators of G-protein signalling.J Physiol 1999; 517:5–23.

    Article  CAS  PubMed  Google Scholar 

  4. Crespo P, Cachero TG, Xu N, et al. Dual effect of beta-adrenergic receptors on mitogen-activated protein kinase. Evidence for a beta gamma-dependent activation and a G alpha s-cAMP-mediated inhibition.J Biol Chem 1995; 270:25259–25265.

    CAS  PubMed  Google Scholar 

  5. Cong M, Perry SJ, Lin FT, et al. Regulation of membrane targeting of the G protein-coupled receptor kinase 2 by protein kinase A and its anchoring protein AKAP79.J Biol Chem 2001; 276: 15192–15199.

    CAS  PubMed  Google Scholar 

  6. Luttrell L, Daaka Y, Lefkowitz R. Regulation of tyrosine kinase cascades by G-protein-coupled receptors.Curr Opin Cell Biol 1999; 11:177–183.

    Article  CAS  PubMed  Google Scholar 

  7. Ahn S, Maudsley S, Luttrell L, et al. Src-mediated tyrosine phosphorylation of dynamin is required for\(\beta _2 - adrenergic\) receptor internalization and mitogen-activated protein kinase signaling.J Biol Chem 1999; 274:1185–1188.

    Article  CAS  PubMed  Google Scholar 

  8. Dzimiri N. Regulation of β-adrenoceptor signaling in cardiac function and disease.Pharmacol Rev 1999; 51:465–501.

    CAS  PubMed  Google Scholar 

  9. Hebert TE, Loisel TP, Adam L, et al. Functional rescue of a constitutively desensitized beta2AR through receptor dimerization.Biochem J 1998; 330 (pt 1):287–293.

    CAS  PubMed  Google Scholar 

  10. Liggett SB. The pharmacogenetics of\(\beta _2 - adrenergic\) receptors: relevance to asthma.J Allergy Clin Immunol 2000; 105:S487-S492.

    Article  CAS  PubMed  Google Scholar 

  11. Schork NJ, Fallin D, Lanchbury JS. Single nucleotide polymorphisms and the future of genetic epidemiology.Clin Genet 2000; 58:250–264.

    Article  CAS  PubMed  Google Scholar 

  12. Gray IC, Campbell DA, Spurr NK. Single nucleotide polymorphisms as tools in human genetics.Hum Mol Genet 2000; 9:2403–2408.

    Article  CAS  PubMed  Google Scholar 

  13. Shi M. Enabling large-scale pharmacogenetic studies by high-throughput mutation detection and genotyping technologies.Clin Chem 2000; 47:164–172.

    Google Scholar 

  14. McLeod HL, Evans WE. Pharmacogenomics: unlocking the human genome for better drug therapy.Annu Rev Pharmacol Toxicol 2001; 41:101–121.

    Article  CAS  PubMed  Google Scholar 

  15. Liu HX, Cartegni L, Zhang MQ, et al. A mechanism for exon skipping caused by nonsense or missense mutations in BRCA1 and other genes.Nat Genet 2001; 27:55–58.

    CAS  PubMed  Google Scholar 

  16. Cargill M, Altshuler D, Ireland J, et al. Characterization of single-nucleotide polymorphisms in coding regions of human genes.Nat Genet 1999; 22:231–238.

    CAS  PubMed  Google Scholar 

  17. Liggett SB. Pharmacogenetics of beta1-and beta2-adrenergic receptors.Pharmacology 2000; 61:167–173.

    Article  CAS  PubMed  Google Scholar 

  18. Cardon LR, Bell JI. Association study designs for complex diseases.Nat Rev Genet 2001; 2:91–99.

    Article  CAS  PubMed  Google Scholar 

  19. Shibata K, Hirasawa A, Moriyama N, et al. Alpha1A-adrenoceptor polymorphism: pharmacological characterization and association with benign prostatic hypertrophy.Br J Pharmacol 1996; 118:1403–1408.

    CAS  PubMed  Google Scholar 

  20. Xie HG, Kim RB, Stein CM, et al. Alpha1A-adrenergic receptor polymorphism: association with ethnicity but not essential hypertension.Pharmacogenetics 1999; 9:651–656.

    CAS  PubMed  Google Scholar 

  21. Stein CM, Lang CC, Singh I, et al. Increased vascular alpha-adrenergic sensitivity in African-Americans [abstract]Clin Pharmacol Ther 1998; 63:176.

    Google Scholar 

  22. Bolonna AA, Arranz MJ, Munro J, et al. No influence of adrenergic receptor polymorphisms on schizophrenia and antipsychotic response.Neurosci Lett 2000; 280:65–68.

    Article  CAS  PubMed  Google Scholar 

  23. Buscher R, Herrmann V, Ring KM, et al. Variability in phenylephrine response and essential hypertension: a search for human alpha(1B)-adrenergic receptor polymorphisms.J Pharmacol Exp Ther 1999; 291:793–798.

    CAS  PubMed  Google Scholar 

  24. Berkowitz DE, Price DT, Bello EA, e al. Localization of messenger RNA for three distinct\(\alpha _2 - adrenergic\) receptor subtypes in human tissues.Anesthesiology 1994; 81:1235–1244.

    CAS  PubMed  Google Scholar 

  25. Sun L, Schulte N, Pettinger P, et al. The frequency of alpha2-adrenoceptor restriction fragment length polymorphisms in normotensive and hypertensive humans.J Hypertens 1992; 10:1011–1015.

    CAS  PubMed  Google Scholar 

  26. Feng J, Sobell JL, Heston LL, et al. Variants in the\(\alpha _{2A} \) AR adrenergic receptor gene in psychiatric patients.Am J Med Genet 1998; 81:405–410.

    CAS  PubMed  Google Scholar 

  27. Baldwin CT, Schwartz F, Baima J, et al. Identification of a polymorphic glutamic acid stretch in the alpha2B-adrenergic receptor and lack of linkage with essential hypertension.Am J Hypertens 1999; 12:853–857.

    Article  CAS  PubMed  Google Scholar 

  28. Small KM, Forbes SL, Brown KM, et al. An asn to lys polymorphism in the third intracellular loop of the human alpha2A-adrenergic receptor imparts enhanced agonist-promoted GI coupling.J Biol Chem 2000; 275:38518–38523.

    CAS  PubMed  Google Scholar 

  29. Lockette W, Ghosh S, Farrow S, et al. Alpha2-adrenergic receptor gene polymorphism and hypertension in blacks.Am J Hypertens 1995; 8:390–394.

    Article  CAS  PubMed  Google Scholar 

  30. Svetkey LP, Timmons PZ, Emovon O, et al. Association of hypertension with\(\beta _2 - \) and\(\alpha _{2C10} - adrenergic\) receptor genotype.Hypertension 1996; 27:1210–1215.

    CAS  PubMed  Google Scholar 

  31. Michel MC, Plogmann C, Philipp T, et al. Functional correlates of alpha2A-adrenoceptor gene polymorphism in the HANE study.Nephrol Dial Transplant 1999; 14:2657–2663.

    CAS  PubMed  Google Scholar 

  32. Freeman K, Farrow S, Schmaier A, et al. Genetic polymorphism of the alpha2-adrenergic receptor is associated with increased platelet aggregation, baroreceptor sensitivity, and salt excretion in normotensive humans.Am J Hypertens 1995; 8:863–869.

    CAS  PubMed  Google Scholar 

  33. Wilson MH, Puranam RS, Ottman R, et al. Evaluation of the\(\alpha _{2A} - adrenergic\) receptor gene in a heritable form of temporal lobe epilepsy.Neurology 1998; 51:1730–1731.

    CAS  PubMed  Google Scholar 

  34. Lario S, Calls J, Cases A, et al. Mspl identifies a biallelic polymorphism in the promoter region of the alpha2A-adrenergic receptor gene.Clin Genet 1997; 51:129–130.

    CAS  PubMed  Google Scholar 

  35. Ohara K, Nagai M, Tani K, et al. Polymorphism in the promoter region of the alpha2A adrenergic receptor gene and mood disorders.Neuroreport 1998; 9:1291–1294.

    CAS  PubMed  Google Scholar 

  36. Ohara K, Suzuki Y, Ochiai M, et al. Polymorphism in the promoter region of the alpha2A-adrenergic receptor gene and panic disorders.Psychiatry Res 2000; 93:79–82.

    Article  CAS  PubMed  Google Scholar 

  37. Heinonen P, Koulu M, Pesonen U, et al. Identification of a three-amino acid deletion in the alpha2B-adrenergic receptor that is associated with reduced basal metabolic rate in obese subjects.J Clin Endocrinol Metab 1999; 84:2429–2433.

    Article  CAS  PubMed  Google Scholar 

  38. Small KM, Forbes SL, Rahman FF, et al. A four amino acid deletion polymorphism in the third intracellular loop of the human alpha2C-adrenergic receptor confers impaired coupling to multiple effectors.J Biol Chem 2000; 275:23059–23064.

    CAS  PubMed  Google Scholar 

  39. Mason DA, Moore JD, Green SA, et al. A gain-of-function polymorphism in a G-protein coupling domain of the human beta1-adrenergic receptor.J Biol Chem 1999; 274:12670–12674.

    CAS  PubMed  Google Scholar 

  40. Tesson F, Charron P, Peuchmaurd M, et al. Characterization of a unique genetic variant in the beta1-adrenoceptor gene and evaluation of its role in idiopathic dilated cardiomyopathy. CARDIGENE Group.J Mol Cell Cardiol 1999; 31:1025–1032.

    Article  CAS  PubMed  Google Scholar 

  41. O'Shaughnessy KM, Fu B, Dickerson C, et al. The gain-of-function G389R variant of the beta1-adrenoceptor does not influence blood pressure or heart rate response to beta-blockade in hypertensive subjects.Clin Sci (Colch) 2000; 99:233–238.

    Google Scholar 

  42. Podlowski S, Wenzel K, Luther HP, et al.\(\beta _1 - Adrenoceptor\) gene variations: a role in idiopathic dilated cardiomyopathy.J Mol Med 2000; 78:87–93.

    Article  CAS  PubMed  Google Scholar 

  43. Börjesson M, Magnusson Y, Hjalmarson Å, et al. A novel polymorphism in the gene coding for the beta1-adrenergic receptor associated with survival in patients with heart failure.Eur Heart J 2000; 21:1853–1858.

    PubMed  Google Scholar 

  44. Reihsaus E, Innis M, MacIntyre N, et al. Mutations in the gene encoding for the beta2-adrenergic receptor in normal and asthmatic subjects.Am J Respir Cell Mol Biol 1993; 8:334–339.

    CAS  PubMed  Google Scholar 

  45. Xie HG, Stein CM, Kim RB, et al. Human beta2-adrenergic receptor polymorphisms: no association with essential hypertension in black or white Americans.Clin Pharmacol Ther 2000; 67:670–675.

    Article  CAS  PubMed  Google Scholar 

  46. Martinez FD, Graves PE, Baldini M, et al. Association between genetic polymorphisms of the beta2-adrenoceptor and response to albuterol in children with and without a history of wheezing.J Clin Invest 1997; 100:3184–3188.

    CAS  PubMed  Google Scholar 

  47. Dewar JC, Wheatley AP, Venn A, et al. Beta2-adrenoceptor polymorphisms are in linkage disequilibrium, but are not associated with asthma in an adult population.Clin Exper Allergy 1998; 28:442–448.

    CAS  Google Scholar 

  48. McGraw DW, Forbes SL, Kramer LA et al. Polymorphisms of the 5′ leader cistron of the human beta2-adrenergic receptor regulate receptor expression.J Clin Invest 1998; 102:1927–1932.

    CAS  PubMed  Google Scholar 

  49. Green SA, Turki J, Innis M, et al. Amino-terminal polymorphisms of the human beta2-adrenergic receptor impart distinct agonist-promoted regulatory properties.Biochemistry (Mosc) 1994; 33:9414–9419.

    CAS  Google Scholar 

  50. Green SA, Cole G, Jacinto M, et al. A polymorphism of the human beta2-adrenergic receptor within the fourth transmembrane domain alters ligand binding and functional properties of the receptor.J Biol Chem 1993; 268:23116–23121.

    CAS  PubMed  Google Scholar 

  51. Green SA, Turki J, Bejarano P, et al. Influence of\(\beta _2 - adrenergic\) receptor genotypes on signal transduction in human airway smooth muscle cells.Am J Respir Cell Mol Biol 1995; 13:25–33.

    CAS  PubMed  Google Scholar 

  52. Turki J, Pak J, Green SA, et al. Genetic polymorphisms of the beta2-adrenergic receptor in nocturnal and nonnocturnal asthma. Evidence that Gly16 correlates with the nocturnal phenotype.J Clin Invest 1995; 95:1635–1641.

    CAS  PubMed  Google Scholar 

  53. Hall IP, Wheatley A, Wilding P, et al. Association of Glu27 beta2-adrenoceptor polymorphism with lower airway reactivity in asthmatic subjects.Lancet 1995; 345:1213–1214.

    CAS  PubMed  Google Scholar 

  54. D'Amato M, Vitiani LR, Petrelli G, et al. Association of persistent bronchial hyperresponsiveness with\(\beta _2 - adrenoceptor\) (ADRB2) haplotypes.Am J Respir Crit Care Med 1998; 158:1968–1973.

    PubMed  Google Scholar 

  55. Lipworth BJ, Hall IP, Aziz I, et al. Beta2-adrenoceptor polymorphism and bronchoprotective sensitivity with regular short- and long-acting beta2-agonist therapy.Clin Sci 1999; 96:253–259.

    CAS  PubMed  Google Scholar 

  56. Lima JJ, Thomason DB, Mohamed MH, et al. Impact of genetic polymorphisms of the beta2-adrenergic receptor on albuterol bronchodilator pharmacodynamics.Clin Pharmacol Ther 1999; 65:519–525.

    CAS  PubMed  Google Scholar 

  57. Busjahn A, Li GH, Faulhaber HD, et al. Beta2-adrenergic receptor gene variations, blood pressure, and heart size in normal twins.Hypertension 2000; 35:555–560.

    CAS  PubMed  Google Scholar 

  58. Gratze G, Fortin J, Labugger R, et al. Beta2-adrenergic receptor variants affect resting blood pressure and agonist-induced vasodilation in young adult Caucasians.Hypertension 1999; 33:1425–1430.

    CAS  PubMed  Google Scholar 

  59. Hoit BD, Suresh DP, Craft L, et al. Beta2-adrenergic receptor polymorphisms at amino acid 16 differentially influence agonist-stimulated blood pressure and peripheral blood flow in normal individuals.Am Heart J 2000; 139:537–542.

    CAS  PubMed  Google Scholar 

  60. Cockcroft JR, Gazis AG, Cross DJ, et al. Beta2-adrenoceptor polymorphism determines vascular reactivity in humans.Hypertension 2000; 36:371–375.

    CAS  PubMed  Google Scholar 

  61. Kotanko P, Binder A, Tasker J, et al. Essential hypertension in African Caribbeans associates with a variant of the\(\beta _2 - adrenoceptor\).Hypertension 1997; 30:773–776.

    CAS  PubMed  Google Scholar 

  62. Candy G, Samani N, Norton G, et al. Association analysis of beta2 adrenoceptor polymorphisms with hypertension in a Black African population.J Hypertens 2000; 18:167–172.

    Article  CAS  PubMed  Google Scholar 

  63. Timmermann B, Mo R, Luft FC, et al.\(\beta _2 - Adrenoceptor\) genetic variation is associated with genetic predisposition to essential hypertension: the Bergen blood pressure study.Kidney Int 1998; 53:1455–1460.

    Article  CAS  PubMed  Google Scholar 

  64. Large V, Hellstrom L, Reynisdottir S, et al. Human beta2-adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte beta2-adrenoceptor function.J Clin Invest 1997; 100:3005–3013.

    CAS  PubMed  Google Scholar 

  65. Arner P, Hoffstedt J. Adrenoceptor genes in human obesity.J Intern Med 1999; 245:667–672.

    Article  CAS  PubMed  Google Scholar 

  66. Ishiyama-Shigemoto S, Yamada K, Yuan X, et al. Association of polymorphisms in the beta2-adrenergic receptor gene with obesity, hypertriglyceridaemia, and diabetes mellitus.Diabetologia 1999; 42:98–101.

    Article  CAS  PubMed  Google Scholar 

  67. Oberkofler H, Esterbauer H, Hell E, et al. The Gln27Glu polymorphism in the beta2-adrenergic receptor gene is not associated with morbid obesity in Austrian women.Int J Obes Relat Metab Disord 2000; 24:388–390.

    Article  CAS  PubMed  Google Scholar 

  68. Xu BY, Huang D, Pirksanen R, et al. Beta2-adrenergic receptor gene polymorphisms in myasthenia gravis (MG).Clin Exp Immunol 2000; 119:156–160.

    Article  CAS  PubMed  Google Scholar 

  69. Liggett SB, Wagoner LE, Craft LL, et al. The Ile 164 beta2-adrenergic receptor polymorphism adversely affects the outcome of congestive heart failure.Clin Invest 1998; 102:1534–1539.

    CAS  Google Scholar 

  70. Wagoner LE, Craft LL, Singh B, et al. Polymorphisms of the beta2-adrenergic receptor determine exercise capacity in patients with heart failure.Circ Res 2000; 86:834–840.

    CAS  PubMed  Google Scholar 

  71. Brodde OE, Buscher R, Tellkamp R, et al. Blunted cardiac responses to receptor activation in subjects with Thr164Ile beta2-adrenoceptors.Circulation 2001; 103:1048–1050.

    CAS  PubMed  Google Scholar 

  72. Candelore MR, Deng L, Tota LM, et al. Pharmacological characterization of a recently described human beta3-adrenergic receptor mutant.Endocrinology 1996; 137:2638–2641.

    Article  CAS  PubMed  Google Scholar 

  73. Pietri-Rouxel F, Manning B, Gros J, et al. The biochemical effect of the naturally occurring Trp64->Arg mutation on human beta1-adrenoceptor activity.Eur J Biochem 1997; 247:1174–1179.

    Article  CAS  PubMed  Google Scholar 

  74. Widen E, Lehto M, Kanninen T, et al. Association of a polymorphism in the beta3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns.N Engl J Med 1995; 333:348–351.

    Article  CAS  PubMed  Google Scholar 

  75. Walston J, Silver K, Bogardus C, et al. Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the\(\beta _3 - adrenergic - receptor\) gene.N Engl J Med 1995; 333:343–347.

    Article  CAS  PubMed  Google Scholar 

  76. Clément K, Vaisse C, Manning BStJ, et al. Genetic variation in the\(\beta _3 - adrenergic\) receptor and an increased capacity to gain weight in patients with morbid obesity.N Engl J Med 1995; 333:352–354.

    PubMed  Google Scholar 

  77. Shihara N, Yasuda K, Moritani T, et al. The association between Trp64Arg polymorphism of the beta3-adrenergic receptor and autonomic nervous system activity.J Clin Endocrinol Metab 1999; 84:1623–1627.

    Article  CAS  PubMed  Google Scholar 

  78. Nagase T, Aoki A, Yamamoto M, et al. Lack of association between the Trp64Arg mutation in the\(\beta _3 - adrenergic\) receptor gene and obesity in Japanese men: a longitudinal analysis.J Clin Endocrinol Metab 1997; 82:1284–1287.

    Article  CAS  PubMed  Google Scholar 

  79. Buettner R, Schaffler A, Arndt H, et al. The Trp64Arg polymorphism of the beta3-adrenergic receptor gene is not associated with obesity or type 2 diabetes mellitus in a large population-based Caucasian cohort.J Clin Endocrinol Metab 1988; 83:2892–2897.

    Google Scholar 

  80. Ghosh S, Langefeld CD, Ally D, et al. The W64R variant of the beta3-adrenergic receptor is not associated with type II diabetes or obesity in a large Finnish sample.Diabetologia 1999; 42:238–244.

    Article  CAS  PubMed  Google Scholar 

  81. Mitchell BD, Blangero J, Comuzzie AG, et al. A paired sibling analysis of the beta3-adrenergic receptor and obesity in Mexican Americans.J Clin Invest 1998; 101:584–587.

    CAS  PubMed  Google Scholar 

  82. Fujisawa T, Ikegami H, Kawaguchi Y, et al. Meta-analysis of the association of Trp64Arg polymorphism of beta3-adrenergic receptor gene with body mass index.J Clin Endocrinol Metab 1998; 83:2441–2444.

    Article  CAS  PubMed  Google Scholar 

  83. Allison DB, Heo M, Faith MS, et al. Meta-analysis of the association of the Trp64Arg polymorphism in the beta3-adrenergic receptor with body mass index.Int J Obes Relat Metab Disord 1998; 22:559–566.

    Article  CAS  PubMed  Google Scholar 

  84. Pulkkinen A, Kareinen A, Saarinen L, et al. The codon 64 polymorphism of the beta3-adrenergic receptor gene is not associated with coronary heart disease or insulin resistance in nondiabetic subjects and non-insulin-dependent diabetic patients.Metabolism 1999; 48:853–856.

    Article  CAS  PubMed  Google Scholar 

  85. Vendrell J, Gutierrez C, Broch M, et al. Beta3-adrenoreceptor gene polymorphism and leptin. Lack of relationship in type 2 diabetic patients.Clin Endocrinol (Oxf) 1998; 49:679–683.

    Article  CAS  Google Scholar 

  86. Tarnow L, Urhammer SA, Mottlau B, et al. The Trp64Arg amino acid polymorphism of the beta3-adrenergic receptor gene does not contribute to the genetic susceptibility of diabetic microvascular complications in Caucasian type 1 diabetic patients.Nephrol Dial Transplant 1999; 14:895–897.

    CAS  PubMed  Google Scholar 

  87. McCarthy JJ, Hilfiker R. The use of single-nucleotide polymorphism maps in pharmacogenomics.Nat Biotechnol 2000; 18:505–508.

    Article  CAS  PubMed  Google Scholar 

  88. Roden DM, Brown NJ. Preprescription genotyping: not yet ready for prime time, but getting there.Circulation 2001; 103:1608–1610.

    CAS  PubMed  Google Scholar 

  89. Turki J, Lorenz JN, Green SA, et al. Myocardial signaling defects and impaired cardiac function of a human beta2-adrenergic receptor polymorphism expressed in transgenic mice.Proc Natl Acad Sci U S A 1996; 93:10483–10488.

    Article  CAS  PubMed  Google Scholar 

  90. Xie HG, Stein CM, Kim RB, et al. Frequency of functionally important beta2-adrenoceptor polymorphisms varies markedly among African-American, Caucasian and Chinese individuals.Pharmacogenetics 1999; 9:511–516.

    CAS  PubMed  Google Scholar 

  91. Ramsay CE, Hayden CM, Tiller KJ, et al. Association of polymorphisms in the beta2-adrenoreceptor gene with higher levels of parasitic infection.Hum Genet 1999; 104:269–274.

    Article  CAS  PubMed  Google Scholar 

  92. Lipworth BJ, Hall IP, Tan S, et al. Effects of genetic polymorphism on ex vivo and in vivo function of beta2-adrenoceptors in asthmatic patients.Chest 1999; 115:324–328.

    CAS  PubMed  Google Scholar 

  93. Jia H, Sharma P, Hopper R, et al. Beta2-adrenoceptor gene polymorphisms and blood pressure variations in East Anglian Caucasians.J Hypertens 2000; 18:687–693.

    Article  CAS  PubMed  Google Scholar 

  94. Aynacioglu AS, Cascorbi I, Gungor K, et al. Population frequency, mutation linkage and analytical methodology for the Arg16Gly, Gln27Glu and Thr164Ile polymorphisms in the beta2-adrenergic receptor among Turks.Br J Clin Pharmacol 1999; 48:761–764.

    Article  CAS  PubMed  Google Scholar 

  95. Dewar J, Wheatley A, Wilkinson J, et al. Association of the Gln27 beta2-adrenoceptor polymorphism and IgE variability in asthmatic families.Chest 1997; 111:78S-79S.

    CAS  PubMed  Google Scholar 

  96. Festa A, Krugluger W, Shnawa N, et al. Trp64Arg polymorphism of the beta3-adrenergic receptor gene in pregnancy: association with mild gestational diabetes mellitus.J Clin Endocrinol Metab 1999; 84:1695–1699.

    Article  CAS  PubMed  Google Scholar 

  97. Garcia-Rubi E, Starling RD, Tchernof A, et al. Trp64Arg variant of the beta3-adrenoceptor and insulin resistance in obese postmenopausal women.J Clin Endocrinol Metab 1998; 83:4002–4005.

    Article  CAS  PubMed  Google Scholar 

  98. Kim-Motoyama H, Yasuda K, Yamaguchi T, et al. A mutation of the beta3-adrenergic receptor is associated with visceral obesity but decreased serum triglyceride.Diabetologia 1997; 40:469–472.

    Article  CAS  PubMed  Google Scholar 

  99. Hoffstedt J, Poirier O, Thorne A, et al. Polymorphism of the human beta3-adrenoceptor gene forms a well-conserved haplotype that is associated with moderate obesity and altered receptor function.Diabetes 1999; 48:203–205.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Clinical Pharmacology, Departments of Medicine and Pharmacology, Vanderbilt University, 1500 21st Avenue South, Suite 3500, 37212-8210, Nashville, Tennessee, USA

    Emily M. Garland Ph.D. & Italo Biaggioni M.D.

Authors
  1. Emily M. Garland Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Italo Biaggioni M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Italo Biaggioni M.D..

Rights and permissions

Reprints and permissions

About this article

Cite this article

Garland, E.M., Biaggioni, I. Genetic polymorphisms of adrenergic receptors. Clinical Autonomic Research 11, 67–78 (2001). https://doi.org/10.1007/BF02322049

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02322049

Key words

Search

Navigation